精巧なデザインパイプライン miRPipe Small RNA Assay デザインパイプラインは、TaqMan Gene Expression Assays を設計している当社の幅広い経験およびバイオインフォマティクス専門知識に基づいています。発現量の非常に少ないターゲットを検出するための長年にわたり蓄積された経験的データに基づいた設計特性が含まれています。その結果得られる自動化パイプラインには、幅広い small RNA 配列の種類に対応したアッセイの設計を可能とするビルトインのフレキシビリティ特性が備えられています。TaqMan Assay 技術の利点は、ほぼすべての small RNA の解析に理想的で、全く最初の実験から信頼性の高い結果が得られることです。
Ordering information 最初に、特異性および配列の品質がバイオインフォマティクス的に適切な配列ターゲットを特定後、Custom TaqMan Small RNA Assay Design Tool を用いて配列を入力し、アッセイデザインを提出します。この使いやすいツールは、安全性および機密性が確保されています。目的のターゲット配列のアッセイの設計・製造ができない場合、費用は発生しません。
研究用途にのみご使用ください。診断目的には使用できません。
仕様
グリーン機能Sustainable packaging
反応数50 x 20 μL reactions (RT-PCR), 150 x 20 μL reactions (PCR)
製品ラインTaqMan
製品タイプSmall RNA Assay
数量S (50 RT/150 PCR reactions), made to order
出荷条件Room Temperature
対応可能対象150 Reactions
濃度20X (Assay), 5X (RT Primer)
検出法Primer-probe
使用対象(アプリケーション)miRNA analysis
PCR法qPCR
Unit SizeEach
組成および保存条件
• 1 tube containing RT primer at concentration of 5X (XS and S sizes), 20X (M size), or 60X (L size) • 1 tube containing a 20X (XS, S, and M sizes) or 60X (L size) mix of pre-formulated assay (1 probe and 2 primers).
Store at -15 to -25°C.
よくあるご質問(FAQ)
What are the performance specifications of the TaqMan miRNA assays?
The TaqMan miRNA asays are guaranteed to meet the following:
Dynamic Range: > 6 logs10 with > 0.97 linearity (R2 value)
Specificity: Majority of assays have < 5% cross reactivity with closely related sequences. NTC background: Ct > 38.0
Lot-to-Lot Reproducibility: Difference between Ct's < 0.6 Ct when different lots of an assay are run with the same sample and master mix from the same lot on the sample plate
Amplification Efficiency: ranging from 90-110% across 5 logs10
Please see the document TaqMan Assays QPCR Guarantee Program for more details.
What data analysis tools do you recommend?
If you are using an Applied Biosystems instrument, we recommend using Expression Suite to analyze data from the TaqMan MicroRNA Array Cards. After importing the .sds or .eds files, you can perform all the QC and data analysis within the tool. For more details on how to use Expression Suite software, please see this video series:
https://learn.thermofisher.com/courses/view/id/325
Do you have data to back up your claim that your TaqMan MicroRNA Assays can accurately distinguish miRNA targets that differ by a single base? Have you tested each TaqMan MicroRNA Assay that is designed to one of two or more closely-related target sequences?
It is well understood within the miRNA community that designing assays for miRNAs is challenging due to their short length (<22 bases) and closely related sequences. Although we have not tested cross reactivity of every closely related species, we have demonstrated that we can achieve <5% cross reactivity between a single nucleotide mismatch. Specificity of an assay depends on the number of mismatches to its closest homologue, the location of the mismatch, and the surrounding bases, making cross reactivity difficult to predict. As a general rule, the most difficult miRNA targets to discriminate are those with minimal mismatches localized to the 5' region of the sequence, and it is close to impossible to design an assay that discriminates between a single mismatch at the 5' most base. In addition, the assays in our catalog have been designed to provide a balance between specificity and sensitivity: an assay may be very specific but lack the needed sensitivity, or vice versa. To achieve this balance, and to ensure the highest sensitivity and to reduce false positives, TaqMan MicroRNA Assays must have an NTC background Ct > 38.0 and display good linearity across at least 3 logs10 (ideal R2 > 0.98).
What about isomiRs? Will Thermo Fisher Scientific assays give me good quantification if they only detect one isomer and not all of them?
Deep sequencing analysis of mature miRNAs revealed that many miRNAs have either an addition or deletion of 1-3 bases at the 3' and less frequently at the 5' terminal end. These are often referred to as isomiRs. The sequence deposited in miRBase is the canonical sequence derived by aligning sequences from current deep sequencing data. Thus far, there has been no biological relevance attached to these different forms since they exclusively occur outside the seed sequence. For that reason, the changes detected in the expression level of one isomer are proportional to changes within the entire pool. As a result, there may be a shift in raw Ct value using assays targeting two separate isomiRs. However, the relative expression ddCt has been demonstrated to be roughly the same. It should be noted that, although TaqMan MicroRNA Assays are designed to be sequence specific, they will detect a small spectrum of isomiRs. Depending on the number and composition at the 3' end, an assay may detect the +1 and +2 isomiRs but not the -1 or -2 forms.
What I can do to minimize variability when using assays?
Use multiple replicates and consider, when possible, using an overall study control that is used in every assay to monitor potential day-to-day/run-to-run/across study variability.